QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Mar 25, 2013
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Sale
Common Stock
2013-03-21$11.24/sh−25,000$281,000→ 27,112 total - Award
Common Stock
2013-03-22$11.24/sh+11,628$130,699→ 38,740 total - Award
Common Stock
2013-03-22$11.24/sh+19,998$224,778→ 47,110 total - Sale
Common Stock
2013-03-22$11.24/sh−19,998$224,778→ 27,112 total - Award
Common Stock
2013-03-21$11.24/sh+25,000$281,000→ 52,112 total - Sale
Common Stock
2013-03-22$11.24/sh−11,628$130,699→ 27,112 total
Footnotes (2)
- [F1]Same-day-sale exercise of stock options issued under an ISO Grant on July 7, 2005. The stock options vested in four equal installments as follows: July 7, 2006, July 7, 2007, July 7, 2008 and July 7, 2009.
- [F2]Same-day-sale exercise of stock options issued under an NQSO Grant on July 7, 2005. The stock options vested in four equal installments as follows: July 7, 2006, July 7, 2007, July 7, 2008 and July 7, 2009.